Zynex inc.

Overview. Zynex is a world premier pain management device manufacturer & distributor. Our mission is to improve the quality of life for patients suffering from debilitating pain or illness by providing the highest technology and service standards in the electrotherapy industry.Nov 15, 2023 · About Zynex, Inc. Zynex, founded in 1996, develops, manufactures, markets, and sells medical devices used for pain management and rehabilitation as well as non-invasive fluid, sepsis, and laser-based pulse oximetry monitoring systems for use in hospitals. For additional information, please visit: www.zynex.com. Investor Relations Contact: Zynex, Inc. beats earnings expectations. Reported EPS is $0.1, expectations were $0.09. Operator: Good day ladies and gentlemen, and welcome to the Zynex Third Quarter 2023 Earnings Conference Call.Get a real-time Zynex, Inc. (ZYXI) stock price quote with breaking news, financials, statistics, charts and more.WebOn March 6, 2023, Zynex announced that the Company was postponing release of its fourth quarter and full year financial results and conference call initially scheduled for March 6, 2023 to allow ...

Nov 13, 2023 · About Zynex, Inc. Zynex, founded in 1996, develops, manufactures, markets, and sells medical devices used for pain management and rehabilitation as well as non-invasive fluid, sepsis, and laser ...

ZYXI stock had an impressive performance on November 13, 2023. According to CNN Money, there are four analysts who have offered 12-month price forecasts for Zynex Inc. The median target price is $18.25, with a high estimate of $27.00 and a low estimate of $13.00. The current consensus among the four polled investment analysts is …Zynex Inc (NASDAQ:ZYXI) institutional ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds (or held) more than 5% of the ...

Mattel Inc.’s slogan is “The World’s Mattel.” The corporation clearly expresses that its mission is to make a difference in a global scale through effectively serving children in need.The good news is that Zynex is growing revenues, and EBIT margins improved by 11.7 percentage points to 18%, over the last year. Both of which are great metrics to check off for potential growth ...Zynex, Inc., together with its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with ... Zynex, Inc. (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient ...

Jul 12, 2023 · ENGLEWOOD, Colo., July 12, 2023 / PRNewswire / -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced preliminary results for second quarter 2023 and reiterated full-year guidance.

ENGLEWOOD, Colo., Oct. 12, 2023 /PRNewswire/ — Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, will hold a conference call on…

Financial Information. This section of the Zynex Medical InvestorRoom houses up to date financial reporting information and interactive tools to provide you with the resources you need to manipulate and understand our current financial standing. Please note: All data in this section is provided by a 3rd party provider and may be delayed up to ...About Zynex, Inc. Zynex, founded in 1996, develops, manufactures, markets, and sells medical devices used for pain management and rehabilitation as well as non-invasive fluid, sepsis, and laser-based pulse oximetry monitoring systems for use in …Zynex, Inc. founded in 1996, engineers, manufactures and markets neuro-diagnostics, stroke rehabilitation, pain management and cardiac monitoring devices within three subsidiaries. Zynex Medical ...Zynex, Inc., together with its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation ...Zynex, Inc. is a medical device manufacturer that produces and markets electrotherapy devices for use in pain management, physical rehabilitation, neurological diagnosis and cardiac monitoring. Thomas Sandgaard founded Zynex Medical in 1996. The company is based in unincorporated Douglas County, Colorado.Zynex Inc. , which belongs to the Zacks Medical - Products industry, posted revenues of $48.81 million for the quarter ended December 2022, missing the Zacks Consensus Estimate by 1.69%. This ...8 Mei 2023 ... Zynex, Inc. (Nasdaq: ZYXI) is an innovative medical technology company specializing in manufacturing and selling non-invasive medical ...

Nov 15, 2023 · Zynex Inc. Stock Price History. Zynex Inc.’s price is currently down 0.68% so far this month. During the month of November, Zynex Inc.’s stock price has reached a high of $9.54 and a low of $8.68. Over the last year, Zynex Inc. has hit prices as high as $17.25 and as low as $6.88. Year to date, Zynex Inc.’s stock is down 2.69%. Zynex, Inc. manufactures and markets medical devices that treat chronic and acute pain, and activate and train muscles for rehabilitation purposes using electrical stimulation. The company operates in the medical device segment, which includes electrotherapy and pain relieving products. The company operates through its …Nov 13, 2023 · About Zynex, Inc. Zynex, founded in 1996, develops, manufactures, markets, and sells medical devices used for pain management and rehabilitation as well as non-invasive fluid, sepsis, and laser ... ENGLEWOOD, Colo., May 4, 2023 /PRNewswire/ -- Zynex, Inc. ("Zynex") (Nasdaq: ZYXI ), announced today the pricing of its previously announced private offering of $52.5 million aggregate principal ...Our non-invasive medical technology improves the quality of life of patients with functional disability or intractable pain. Our TENS/IFC/NMES NexWave device has revolutionized …WebZynex Inc's (NASDAQ: ZYXI) board of directors approved a program to repurchase up to $20.0 million. The program will commence on November 1, 2023, and is scheduled to terminate earlier than ...

Zynex, Inc. ("Zynex") (Nasdaq: ZYXI), today announced its intent to offer, subject to market conditions and other factors, $50 million aggregate principal amount of …Web

Fax your prescription to 866-791-2026 . If you are with a doctor’s office or physical therapy clinic, please include a cover sheet with the clinic/practice name with your fax. 2. Zynex will take care of the rest! We will call to review insurance information, ship the device to your doorstep, and provide instructions to use it.ENGLEWOOD, Colo., Oct. 19, 2023 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI ), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for ...Q3 2023 Revenue Increased 20% to $49.9 Million; EPS $0.10. ENGLEWOOD, Colo., Oct. 26, 2023 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, has reported its financial and operational results for the third quarter ended ...In 1996, he founded Zynex Inc., and in 1998 his company’s first product acquired Food and Drug Administration (FDA) approval. Sandgaard also founded Sandgaard Capital, a private family office and investment firm, and Sandgaard Foundation. He also owns Clear Ocean Capital Limited. He bought Charlton Athletic Football Club from East Street ...Nov 15, 2023 · ENGLEWOOD, Colo., Nov. 15, 2023 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced the Company has been ranked within Forbes' list of America's Most Successful Small-Cap Companies for 2024. ENGLEWOOD, Colo., Nov. 9, 2023 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced the Company has been ranked among all companies in the U.S. and Canada between 2019 and 2022 on Deloitte's Technology Fast 500.Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient ...Zynex Pro TLSO; OA Knee Brace; Zynex Pro Wrist Brace; Post-Op Knee Brace; Saunders Cervical Traction; ComforTrac Cervical Traction; Zynex CryoHeat; E …Web

Mar 13, 2023 · ENGLEWOOD, Colo., March 13, 2023 / PRNewswire / -- Zynex, Inc. (Nasdaq: ZYXI) an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today reported financial results for the fourth quarter and full year ended December 31, 2022.

Zynex Medical has an overall rating of 4.2 out of 5, based on over 633 reviews left anonymously by employees. 81% of employees would recommend working at Zynex Medical to a friend and 78% have a positive outlook for the business. This rating has decreased by -7% over the last 12 months.

Our mission is to improve the quality of life of patients suffering from debilitating pain or illnesses by providing the highest technology and service standards in the electrotherapy industry. Our non-invasive medical technology improves the quality of life of patients with functional disability or intractable pain.Zynex, Inc. (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient ...Zynex, Inc. Common Stock (ZYXI) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.Zynex, Inc., together with its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with ... Mattel Inc.’s slogan is “The World’s Mattel.” The corporation clearly expresses that its mission is to make a difference in a global scale through effectively serving children in need.JetStream (Discontinued) Patented ATC™ Measures and regulates temperature to provide therapeutic hot and cold therapy without manual adjustment. We specialize in offering patients simple and safe ways to manage their pain to improve their quality of life. Opioid free and prescription strength. ENGLEWOOD, Colo., March 13, 2023 / PRNewswire / -- Zynex, Inc. (Nasdaq: ZYXI) an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today reported financial results for the fourth quarter and full year ended …Mar 13, 2023 · Zynex, Inc. (Nasdaq: ZYXI) an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient ... Zynex Inc. , which belongs to the Zacks Medical - Products industry, posted revenues of $49.92 million for the quarter ended September 2023, surpassing the Zacks Consensus Estimate by 0.84%.0.49%. $58.97M. ZYXI | Complete Zynex Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.Web

Mar 13, 2023 · Zynex Inc. (ZYXI) delivered earnings and revenue surprises of 5.26% and 1.69%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock? ZYXI stock had an impressive performance on November 13, 2023. According to CNN Money, there are four analysts who have offered 12-month price forecasts for Zynex Inc. The median target price is $18.25, with a high estimate of $27.00 and a low estimate of $13.00. The current consensus among the four polled investment analysts is …ZYXI stock had an impressive performance on November 13, 2023. According to CNN Money, there are four analysts who have offered 12-month price forecasts for Zynex Inc. The median target price is $18.25, with a high estimate of $27.00 and a low estimate of $13.00. The current consensus among the four polled investment analysts is …In August 2023, the company introduced three new pain management therapy products, including the Zynex Pro Thoracic Lumbar Sacral Orthosis (“TLSO”), Zynex Pro ...Instagram:https://instagram. oppenheimer stockmutual fund brokeronfoliosafely short term rental insurance Live Chat Inc. is a tool you can use to interact with customers or clients on the internet. More and more, consumers are demanding and expecting immediate help from the companies they approach. This application enables you to engage with cu... stock symbolseli lilly ozempic Nov 13, 2023 · ZYXI stock had an impressive performance on November 13, 2023. According to CNN Money, there are four analysts who have offered 12-month price forecasts for Zynex Inc. The median target price is $18.25, with a high estimate of $27.00 and a low estimate of $13.00. The current consensus among the four polled investment analysts is to buy stock in ... Mattel Inc.’s slogan is “The World’s Mattel.” The corporation clearly expresses that its mission is to make a difference in a global scale through effectively serving children in need. safehold stock ENGLEWOOD, Colo., March 13, 2023 / PRNewswire / -- Zynex, Inc. (Nasdaq: ZYXI) an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today reported financial results for the fourth quarter and full year ended …Under the SEC program, whistleblowers who provide original information may, under certain circumstances, receive rewards totaling up to thirty percent of any successful recovery made by the SEC ...